Navigation Links
Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
Date:9/4/2008

facturing facilities -- totaling approximately 400,000 square feet and offering both small-scale and large-scale production in batches from 650- 20,000 liters.

"The manufacturing alliance with HGS is an excellent strategic partnership for both companies and is representative of Hospira's commitment to meet future demand for high-quality, cost-effective alternatives to proprietary biopharmaceuticals," said John Lane, Vice President, Biologics, Hospira, Inc. "By securing access to HGS' leading-edge technology in late-stage process development and large-scale biopharmaceutical manufacturing capability, we also defer the immediate need to invest in additional Hospira facilities for the manufacture of these biologic products."

In addition to the agreement with Hospira announced today, HGS entered into a marketing services agreement with Eden Biodesign Ltd. in mid-August 2008, under which Eden Biodesign will assist HGS in identifying other large- scale manufacturing and late-stage process development clients.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediate
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
2. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
3. UC Riverside researcher develops novel method to grow human embryonic stem cells
4. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
5. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
6. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
7. Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
8. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
9. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
10. New map IDs the core of the human brain
11. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 The global market for biotechnology ... according to a new study by Grand View Research, ... for effective vaccines and drugs in an attempt to ... is expected to drive market demand over the next ... productivity via the use of genetically engineered seeds is ...
(Date:7/26/2014)... 2014 Canada Endoscopy Visualization Systems ... on the Canada Endoscopy Visualization Systems market. The ... volume (in units) and average prices (in US ... Systems, Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy ... http://www.marketresearchreports.biz/analysis/213254 . , The report also provides company ...
(Date:7/25/2014)... July 25, 2014 Research and ... "Global Metabolomics Market 2014-2018" report to their ... Metabolomics or Metabonomics is the scientific ... become a new experimental technique that is being ... sciences. Metabolites are small molecules that are present ...
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
Breaking Biology Technology:Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6
... Osteotech, Inc.,(Nasdaq: OSTE ), a leader in ... today that revenue for the three months,ended September 30, ... three months ended September 30, 2007. The decline in ... primarily driven by a $2.8,million reduction in private label ...
... SHANGHAI, China, Nov. 7 /Xinhua-PRNewswire/ -- WuXi ... medical device research,and development outsourcing company with ... today that it has signed a new ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), ...
... are developing technologies that will fuel the continued growth ... financial boost through the 2008 Clean Tech Innovation Challenge. ... partnership between the City of San Diego, UC San ... San Diego State University (SDSU). The program is designed ...
Cached Biology Technology:Osteotech Reports 2008 Third Quarter Financial Results 2Osteotech Reports 2008 Third Quarter Financial Results 3Osteotech Reports 2008 Third Quarter Financial Results 4Osteotech Reports 2008 Third Quarter Financial Results 5WuXi PharmaTech Signs New Collaboration Agreement With Pfizer 2San Diego universities, government and industry rally around local Clean-Tech cluster 2San Diego universities, government and industry rally around local Clean-Tech cluster 3San Diego universities, government and industry rally around local Clean-Tech cluster 4San Diego universities, government and industry rally around local Clean-Tech cluster 5
(Date:7/28/2014)... led by the University of Arizona has sequenced the ... will enhance scientists, and agriculturalists, understanding of the growing ... development of new rice varieties that are better able ... global hunger challenges. , The paper, "The genome sequence ... for independent domestication," was published online in Nature ...
(Date:7/28/2014)... juvenile rat brain cells suggests that the effects of ... brain cells are temporary. , The study, published in ... , was conducted by biologists at the University of ... New York in response to concerns, arising from multiple ... children to general anesthetics may increase their susceptibility to ...
(Date:7/28/2014)... New research has identified areas of the Earth that ... climate change. , Europe is particularly vulnerable, as it ... four per cent, of any continent in ,refugia, ... natural environmental conditions remain relatively constant during times of ... Europe are mostly in Scandinavia and Scotland. , ...
Breaking Biology News(10 mins):Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2
... (DIYbio) community has grown, so have concerns among media ... DNA and manipulate life. In 2009, for example, ... the popular misconception: "In Attics and Closets, ,Biohackers, Discover ... survey of DIYbio practitioners (DIYers), the Synthetic Biology Project ...
... years ago, mammalian target of rapamycin or mTOR, a ... the antidepressant effects of ketamine, the first rapidly acting ... later, a group at the National Institutes of Mental ... receptor antagonist, also produced rapidly appearing antidepressant effects, similar ...
... APOPKA, FL--Shade nets are widely used in ornamental crop ... and birds. According to a 2011 study from the ... production in the United States occurred under shade or ... growers have begun experimenting with colored, gray, and white ...
Cached Biology News:First-ever survey of Do-It-Yourself Biology community challenges myths 2mTOR: A key brain signaling mechanism for rapidly acting antidepressants 2Shadehouses with photoselective nets featured in study of growing conditions 2
Edited by I.H. Pawlowitzki, J.H. Edwards and E.A. Thompson (1997) • This volume covers: Linkage in dominant recessive and oligogenic disease, Model free (non-parametric) methods, Tools for gene ...
... Cloning is the most ... cloning PCR products. TOPO ... Blunt TOPO vectors are ... with topoisomerase I. This ...
Applications: ISH...
... ZMD.420. Immunogen: Recombinant human ... Specific for the ~44 kDa ... Human (positive control: IFN-Gamma-stimmulated Human ... sequence homology reactivity with mouse ...
Biology Products: